Related Experiment Videos
Mesenteric desmoid with uptake on gallium-67 citrate scintigraphy
S Shiomi1, S Nishiguchi, A Montani
1Division of Nuclear Medicine, Osaka City University Medical School, Osaka, Japan. shiomis@med.osaka-cu.ac.jp
Annals of Nuclear Medicine
|September 8, 2001
Summary
Mesenteric desmoid tumors, a type of abdominal mass, can show high uptake of Gallium-67 citrate (Ga-67). This finding is based on a case study of a 72-year-old man with a diagnosed abdominal desmoid tumor.
Area of Science:
- Oncology
- Nuclear Medicine
- Diagnostic Imaging
Background:
- Desmoid tumors are rare, fibrous neoplasms that can occur in various locations.
- Abdominal desmoid tumors are less common and can present as space-occupying lesions.
- Gallium-67 citrate (Ga-67) scintigraphy is a nuclear medicine imaging technique used to detect inflammation and certain tumors.
Observation:
- A 72-year-old male patient presented with an abdominal space-occupying lesion.
- Magnetic resonance imaging (MRI) identified a 40 mm abdominal tumor.
- Anterior Ga-67 citrate scintigraphy demonstrated significant radiotracer uptake in the abdominal region corresponding to the tumor.
Findings:
- Histological examination of the excised tumor confirmed a diagnosis of mesenteric desmoid.
- The case suggests that mesenteric desmoid tumors can exhibit high Ga-67 uptake.
- This observation indicates potential utility of Ga-67 scintigraphy in evaluating desmoid tumors.
Implications:
- Ga-67 scintigraphy may serve as a valuable diagnostic tool for mesenteric desmoid tumors.
- Understanding Ga-67 uptake patterns can aid in the diagnosis and management of desmoid tumors.
- Further research is warranted to explore the role of Ga-67 in the broader spectrum of desmoid tumor evaluation.